Litracen

Litracen (N-7,049) is a tricyclic antidepressant which was never marketed.[1][2]

Litracen
Clinical data
Routes of
administration		Oral
ATC code
  • none
Legal status
Legal status
  • In general: uncontrolled
Identifiers
IUPAC name
  • 3-(10,10-dimethylanthracen-9(10H)-ylidene)-N-methylpropan-1-amine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC20H23N
Molar mass277.411 g·mol−1
3D model (JSmol)
SMILES
  • c3ccc2c(/C(c1c(cccc1)C2(C)C)=C\CCNC)c3

Synthesis

Patents:[3][4]

10,10-dimethylanthrone [5447-86-9]

See also

References
  1. David J. Triggle (1996). Dictionary of Pharmacological Agents. Boca Raton: Chapman & Hall/CRC. ISBN 0-412-46630-9.
  2. Nielsen IM, Nymark M, Hougs W, Pedersen V (February 1966). "The pharmacological properties of melitracen (N 7001) and litracen (N 7049)". Arzneimittel-Forschung. 16 (2): 135–40. PMID 6014004.
  3. , FR 1345936 (1963-12-13 to Kefalas AS); CA, 60, 15891e (synth, pharmacol)
  4. GB939856 idem Torkil O Holm, U.S. Patent 3,177,209 (1965 to Kefalas As).
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.